{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:19:58Z","timestamp":1791209998988,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s11695-025-08137-4","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T04:10:21Z","timestamp":1754712621000},"page":"3939-3946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Preoperative Glucagon-Like Peptide-1 Receptor Agonists and Bariatric Surgery Outcomes: A Systematic Review"],"prefix":"10.1007","volume":"35","author":[{"given":"Ali","family":"Esparham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Sheikhbahaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengameh","family":"Anari Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhamak","family":"Khorgami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"issue":"19","key":"8137_CR1","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2146\/ajhp150990","volume":"73","author":"D Isaacs","year":"2016","unstructured":"Isaacs D, Prasad-Reddy L, Srivastava SB. Role of glucagon-like peptide 1 receptor agonists in management of obesity. Am J Health-Syst Pharm. 2016;73(19):1493\u2013507.","journal-title":"Am J Health-Syst Pharm"},{"key":"8137_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.peptides.2017.12.009","volume":"100","author":"E Brown","year":"2018","unstructured":"Brown E, Cuthbertson DJ, Wilding JP. Newer GLP-1 receptor agonists and obesity-diabetes. Peptides. 2018;100:61\u20137.","journal-title":"Peptides"},{"issue":"2","key":"8137_CR3","first-page":"168","volume":"46","author":"DEOA Perez-Montes","year":"2021","unstructured":"Perez-Montes DEOA, Pellitero S, Puig-Domingo M. Obesity and GLP-1. Minerva Endocrinol (Torino). 2021;46(2):168\u201376.","journal-title":"Minerva Endocrinol (Torino)"},{"issue":"11","key":"8137_CR4","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1002\/oby.23563","volume":"30","author":"S Sarma","year":"2022","unstructured":"Sarma S, Palcu P. Weight loss between glucagon-like peptide-1 receptor agonists and bariatric surgery in adults with obesity: a systematic review and meta-analysis. Obesity. 2022;30(11):2111\u201321.","journal-title":"Obesity"},{"issue":"12","key":"8137_CR5","doi-asserted-by":"publisher","first-page":"9509","DOI":"10.1007\/s00464-023-10387-1","volume":"37","author":"M Ilanga","year":"2023","unstructured":"Ilanga M, Heard JC, McClintic J et al. Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study. Surg Endosc. 2023;37(12):9509\u201313.","journal-title":"Surg Endosc"},{"issue":"3","key":"8137_CR6","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/dom.13131","volume":"20","author":"T Tang","year":"2018","unstructured":"Tang T, Abbott S, le Roux CW et al. Preoperative weight loss with glucagon-like peptide-1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: a longitudinal analysis. Diabetes Obes Metab. 2018;20(3):745\u20138.","journal-title":"Diabetes Obes Metab"},{"key":"8137_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102785","author":"MA Rubio-Herrera","year":"2023","unstructured":"Rubio-Herrera MA, Mera-Carreiro S, S\u00e1nchez-Pernaute A et al. Impact of treatment with GLP1 receptor agonists, liraglutide 3.0 mg and semaglutide 1.0 mg, while on a waiting list for bariatric surgery. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11102785.","journal-title":"Biomedicines"},{"issue":"11","key":"8137_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13811","volume":"25","author":"A Esparham","year":"2024","unstructured":"Esparham A, Mehri A, Dalili A et al. Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: a systematic review and meta-analysis. Obes Rev. 2024;25(11): e13811.","journal-title":"Obes Rev"},{"key":"8137_CR9","doi-asserted-by":"crossref","unstructured":"Cassie S, Menezes C, Birch DW et al. Effect of preoperative weight loss in bariatric surgical patients: a systematic review. Surg Obes Relat Dis. 2011;7(6):760\u20137; discussion 7.","DOI":"10.1016\/j.soard.2011.08.011"},{"key":"8137_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2025.0001","author":"V Mathur","year":"2025","unstructured":"Mathur V, Wasden K, Shin TH et al. Neoadjuvant semaglutide, bariatric surgery weight loss, and overall outcomes. JAMA Surg. 2025. https:\/\/doi.org\/10.1001\/jamasurg.2025.0001.","journal-title":"JAMA Surg"},{"issue":"5","key":"8137_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000531459","volume":"16","author":"G Martines","year":"2023","unstructured":"Martines G, Dezi A, Giove C et al. Efficacy of intragastric balloon versus liraglutide as bridge to surgery in super-obese patients. Obes Facts. 2023;16(5):457\u201364.","journal-title":"Obes Facts"},{"issue":"2","key":"8137_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s11695-024-07651-1","volume":"35","author":"Q AbuHasan","year":"2025","unstructured":"AbuHasan Q, Funk LM, Holl JL et al. Preoperative glucagon-like peptide-1 receptor agonist utilization and association with bariatric surgery outcomes. Obes Surg. 2025;35(2):556\u201360.","journal-title":"Obes Surg"},{"issue":"11","key":"8137_CR13","doi-asserted-by":"publisher","first-page":"8503","DOI":"10.1007\/s00464-022-09294-8","volume":"36","author":"M Hakim","year":"2022","unstructured":"Hakim M, Fathi M, Abdulraziq M et al. Incidence of adhesions in patients using liraglutide before laparoscopic sleeve gastrectomy. Surg Endosc. 2022;36(11):8503\u20138.","journal-title":"Surg Endosc"},{"key":"8137_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.clnesp.2022.05.009","volume":"50","author":"C Stier","year":"2022","unstructured":"Stier C, Koschker AC, Kim M et al. Fast-track rescue weight reduction therapy to achieve rapid technical operability for emergency bariatric surgery in patients with life-threatening inoperable severe obesity - a proof of concept study. Clin Nutr ESPEN. 2022;50:238\u201346.","journal-title":"Clin Nutr ESPEN"},{"key":"8137_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2022.100450","volume":"35","author":"DB Amusin","year":"2022","unstructured":"Amusin DB, Kuchta K, Ewing T et al. Association between hemoglobin A1C response to glucagon-like peptide-1 receptor agonists and hemoglobin A1C and weight outcomes post-bariatric surgery. Obes Med. 2022;35: 100450.","journal-title":"Obes Med"},{"issue":"1","key":"8137_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/SLA.0000000000000588","volume":"261","author":"GC Wood","year":"2015","unstructured":"Wood GC, Gerhard GS, Benotti P et al. Preoperative use of incretins is associated with increased diabetes remission after RYGB surgery among patients taking insulin: a retrospective cohort analysis. Ann Surg. 2015;261(1):125\u20138.","journal-title":"Ann Surg"},{"issue":"12","key":"8137_CR17","doi-asserted-by":"publisher","first-page":"7152","DOI":"10.1007\/s00464-024-11231-w","volume":"38","author":"G Martines","year":"2024","unstructured":"Martines G, Giove C, Carlucci B et al. Effect of preoperative liraglutide 3.0 mg on incidence of intraoperative adhesions in laparoscopic sleeve gastrectomy. Surg Endosc. 2024;38(12):7152\u20137.","journal-title":"Surg Endosc"},{"issue":"3","key":"8137_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.soard.2024.09.013","volume":"21","author":"X Shan","year":"2025","unstructured":"Shan X, Wang Y, Xiao X et al. GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study. Surg Obes Relat Dis. 2025;21(3):247\u201355.","journal-title":"Surg Obes Relat Dis"},{"issue":"4","key":"8137_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.soard.2010.10.009","volume":"7","author":"VR Kakarla","year":"2011","unstructured":"Kakarla VR, Nandipati K, Lalla M et al. Are laparoscopic bariatric procedures safe in superobese (BMI \u226550 kg\/m2) patients? An NSQIP data analysis. Surg Obes Relat Dis. 2011;7(4):452\u20138.","journal-title":"Surg Obes Relat Dis"},{"issue":"8","key":"8137_CR20","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/OGX.0000000000000469","volume":"72","author":"MC Smid","year":"2017","unstructured":"Smid MC, Dotters-Katz SK, Silver RM et al. Body mass index 50 kg\/m2 and beyond: perioperative care of pregnant women with superobesity undergoing cesarean delivery. Obstet Gynecol Surv. 2017;72(8):500\u201310.","journal-title":"Obstet Gynecol Surv"},{"issue":"12","key":"8137_CR21","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.jse.2015.05.046","volume":"24","author":"BC Werner","year":"2015","unstructured":"Werner BC, Burrus MT, Browne JA et al. Superobesity (body mass index >50 kg\/m2) and complications after total shoulder arthroplasty: an incremental effect of increasing body mass index. J Shoulder Elbow Surg. 2015;24(12):1868\u201375.","journal-title":"J Shoulder Elbow Surg"},{"issue":"8","key":"8137_CR22","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1111\/dom.15636","volume":"26","author":"DC Klonoff","year":"2024","unstructured":"Klonoff DC, Kim SH, Galindo RJ et al. Risks of peri- and postoperative complications with glucagon-like peptide-1 receptor agonists. Diabetes Obes Metab. 2024;26(8):3128\u201336.","journal-title":"Diabetes Obes Metab"},{"key":"8137_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-025-07838-0","author":"M Kermansaravi","year":"2025","unstructured":"Kermansaravi M, Esparham A, Parmar C et al. Intragastric balloon as a bridge before metabolic and bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2025. https:\/\/doi.org\/10.1007\/s11695-025-07838-0.","journal-title":"Obes Surg"},{"issue":"3","key":"8137_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.neuron.2020.11.010","volume":"109","author":"C Zhang","year":"2021","unstructured":"Zhang C, Kaye JA, Cai Z et al. Area postrema cell types that mediate nausea-associated behaviors. Neuron. 2021;109(3):461-72.e5.","journal-title":"Neuron"},{"issue":"7","key":"8137_CR25","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1523\/JNEUROSCI.23-07-02939.2003","volume":"23","author":"H Yamamoto","year":"2003","unstructured":"Yamamoto H, Kishi T, Lee CE et al. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J Neurosci. 2003;23(7):2939\u201346.","journal-title":"J Neurosci"},{"issue":"5","key":"8137_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.diabet.2017.05.009","volume":"43","author":"Y Nakatani","year":"2017","unstructured":"Nakatani Y, Maeda M, Matsumura M et al. Effect of GLP-1 receptor agonist on gastrointestinal tract motility and residue rates as evaluated by capsule endoscopy. Diabetes Metab. 2017;43(5):430\u20137.","journal-title":"Diabetes Metab"},{"key":"8137_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1043789","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu L, Chen J, Wang L et al. Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: a real-world disproportionality study based on FDA adverse event reporting system database. Front Endocrinol (Lausanne). 2022;13: 1043789.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"8137_CR28","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.2337\/dc12-2713","volume":"36","author":"PC Butler","year":"2013","unstructured":"Butler PC, Elashoff M, Elashoff R et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care. 2013;36(7):2118\u201325.","journal-title":"Diabetes Care"},{"issue":"7","key":"8137_CR29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/jamainternmed.2013.2720","volume":"173","author":"S Singh","year":"2013","unstructured":"Singh S, Chang HY, Richards TM et al. Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med. 2013;173(7):534\u20139.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"8137_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11\u201322.","journal-title":"N Engl J Med"},{"issue":"10","key":"8137_CR31","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jamainternmed.2016.1531","volume":"176","author":"JL Faillie","year":"2016","unstructured":"Faillie JL, Yu OH, Yin H et al. Association of bile duct and gallbladder diseases with the use of incretin-based drugs in patients with type 2 diabetes mellitus. JAMA Intern Med. 2016;176(10):1474\u201381.","journal-title":"JAMA Intern Med"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-025-08137-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:42:15Z","timestamp":1758638535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-025-08137-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["8137"],"URL":"https:\/\/doi.org\/10.1007\/s11695-025-08137-4","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}